Perspective Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Perspective Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q3 2024.
  • Perspective Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 750M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 750M 0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 750M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 750M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 750M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 750M +550M +275% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 750M +550M +275% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 750M +550M +275% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 750M +550M +275% Dec 31, 2022 10-K 2024-03-28
Q3 2022 200M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 200M 0 0% Jun 30, 2022 10-KT 2023-05-01
Q1 2022 200M 0 0% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 200M 0 0% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 200M 0 0% Jun 30, 2021 10-KT 2023-05-01
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 200M 0 0% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 200M 0 0% Jun 30, 2020 10-K 2021-09-27
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 200M 0 0% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 200M +7M +3.63% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 200M 0 0% Jun 30, 2019 10-K 2020-09-25
Q1 2019 200M +7M +3.63% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 200M +7M +3.63% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 193M 0 0% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 200M +7M +3.63% Jun 30, 2018 10-K 2019-09-27
Q1 2018 193M 0 0% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 193M 0 0% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 193M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 193M 0 0% Jun 30, 2017 10-K 2018-09-26
Q1 2017 193M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 193M 0 0% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 193M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 193M 0 0% Jun 30, 2016 10-K 2017-09-28
Q1 2016 193M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 193M 0 0% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 193M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 193M 0 0% Jun 30, 2015 10-K 2016-09-09
Q1 2015 193M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 193M 0 0% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 193M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 193M -1.67K 0% Jun 30, 2014 10-K 2015-09-14
Q1 2014 193M -1.67K 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 193M -1.67K 0% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 193M -1.67K 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 193M 0 0% Jun 30, 2013 10-K 2014-09-29
Q1 2013 193M 0 0% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 193M 0 0% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 193M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 193M 0 0% Jun 30, 2012 10-K 2013-09-30
Q1 2012 193M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 193M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 193M Sep 30, 2011 10-Q/A 2011-12-13
Q2 2011 193M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.